03:17 AM EDT, 10/23/2024 (MT Newswires) -- Mark W Hahn, Chief Financial Officer, on October 18, 2024, sold 525,768 shares in Verona Pharma ( VRNA ) for $2,303,773. Following the Form 4 filing with the SEC, Hahn has control over a total of 13,813,920 shares of the company, with 13,813,920 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1657312/000110465924110658/xslF345X05/tm2426639-1_4seq1.xml

Price: 34.97, Change: +0.10, Percent Change: +0.29